Evaluation of Tuberculosis Underreporting in Greece through Comparison with Anti-Tuberculosis Drug Consumption

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Lytras, Theodore ^a   Spala, Georgia ^b   Bonovas, Stefanos ^b   Panagiotopoulos, Takis ^a  

^a NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^b Hellenic Centre for Disease Control and Prevention   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ARTICLE; CHEMOPROPHYLAXIS; CHILD; DISEASE SURVEILLANCE; DRUG USE; GREECE; HUMAN; INCIDENCE; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; SCHOOL CHILD; TREATMENT DURATION; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; EPIDEMIOLOGICAL MONITORING; ETHAMBUTOL; GREECE; HUMANS; ISONIAZID; LATENT TUBERCULOSIS; PRESCRIPTION DRUGS; PYRAZINAMIDE; RIFAMPIN; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84869794929     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050033     Document Type: Article

References (27)

1. World Health Organisation (2010) Global tuberculosis control: WHO report 2010. Geneva: WHO. Available: http://www.who.int/tb/publications/global_report/2010/en/index.html. Accessed 2011 Jun 8.
2. Castro KG, (2007) Tuberculosis surveillance: data for decision-making. Clin Infect Dis 44(10): 1268-1270.
3. D'Ambrosio L, Centis R, Spanevello A, Migliori GB (2010) Improving tuberculosis surveillance in Europe is key to controlling the disease. Euro Surveill 15(11): pii = 19513. Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19513. Accessed 2012 Oct 20.
4. World Health Organization (1994) WHO Tuberculosis Programme: framework for effective tuberculosis control. Geneva: WHO. Available: http://whqlibdoc.who.int/hq/1994/WHO_TB_94.179.pdf. Accessed 2012 Mar 22.
5. Pillaye J, Clarke A, (2003) An evaluation of completeness of tuberculosis notification in the United Kingdom. BMC Public Health 3: 31.
6. Baussano I, Bugiani M, Gregori D, van Hest R, Borraccino A, et al. (2006) Undetected burden of tuberculosis in a low-prevalence area. Int J Tuberc Lung Dis 10(4): 415-421.
7. van Hest NA, Smit F, Baars HW, De Vries G, De Haas PE, et al. (2007) Completeness of notification of tuberculosis in The Netherlands: how reliable is record-linkage and capture-recapture analysis? Epidemiol Infect 135(6): 1021-1029.
8. Cojocaru C, van Hest NA, Mihaescu T, Davies PD, (2009) Completeness of notification of adult tuberculosis in Iasi County, Romania: a capture-recapture analysis. Int J Tuberc Lung Dis 13(9): 1094-1099.
9. European Centre for Disease Prevention and Control/WHO Regional Office for Europe (2012) Tuberculosis surveillance and monitoring in Europe 2012. Stockholm: European Centre for Disease Prevention and Control. Available: http://www.ecdc.europa.eu/en/publications/Publications/1203-Annual-TB-Report.pdf. Accessed 2012 Oct 20.
10. Jelastopulu E, Alexopoulos EC, Venieri D, Tsiros G, Komninou G, et al. (2009) Substantial underreporting of tuberculosis in West Greece- implications for local and national surveillance. Euro Surveill 14(11): pii = 19152. Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19152. Accessed 2012 Oct 20.
11. Theodoracopoulos P, Dimadi M, Constantopoulos SH, (1992) Calculation of new cases of tuberculosis from the consumption of antituberculosis medications; comparison with notification rates. Respiration 59(1): 64.
12. World Health Organization (WHO). Treatment of tuberculosis: guidelines for national programmes, 4th ed. Geneva: WHO, 2010 (WHO/HTM/TB/2009.420). Available at: http://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf. Accessed 2012 Mar 22.
13. 2008/426/EC: Commission Decision of 28 April 2008 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council (notified under document number C(2008) 1589). OJ L 159, 18.06.2008, p.46.
14. Papaventsis D, Nikolaou S, Karabela S, Ioannidis P, Konstantinidou E, et al. (2010) Tuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance, 1995-2009. Euro Surveill 15(28): pii = 19614. Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19614. Accessed 2012 Oct 20.
15. WHO Collaborating Centre for Drug Statistics Methodology (2010) Guidelines for ATC classification and DDD assignment 2011. Oslo: WHO Collaborating Centre for Drug Statistics Methodology.
16. Hellenic Centre for Disease Control and Prevention (2004) Guidelines for managing tuberculosis. Athens: Hellenic Centre for Disease Control and Prevention.
17. National Organization for Medicines (2007) National Formulary 2007. Athens: National Organization for Medicines.
18. Kirkwood B, Sterne J (2003) Essential Medical Statistics, 2nd edition. Oxford: Blackwell Publishing.
19. Jereb J, Etkind SC, Joglar OT, Moore M, Taylor Z, (2003) Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999. Int J Tuberc Lung Dis 7(12Suppl 3): S384-390.
20. Langenskiold E, Herrmann FR, Luong BL, Rochat T, Janssens JP, (2008) Contact tracing for tuberculosis and treatment for latent infection in a low incidence country. Swiss Med Wkly 138(5-6): 78-84.
21. del Castillo Otero D, Peñafiel Colás M, Alvarez Gutiérrez F, Soto Campos JG, Calderón Osuna E, et al. (1999) Investigation of tuberculosis contacts in a nonhospital pneumology practice. Eur J Clin Microbiol Infect Dis 18(11): 790-795.
22. Reichler MR, Reves R, Bur S, Thompson V, Mangura BT, et al. (2002) Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA 287(8): 991-995.
23. van Loenhout-Rooyackers JH, Leufkens HG, Hekster YA, Kalisvaart NA, (2001) Pyrazinamide use as a method of estimating under-reporting of tuberculosis. Int J Tuberc Lung Dis 5(12): 1156-1160.
24. Criado-Alvarez JJ, Sanz Cortés J (2004) [Use of pyrazinamide as an indicator of tuberculosis epidemiology in Castilla-La Mancha]. Rev Clin Esp 204(6): 298-302. [Article in Spanish]. Available: http://www.elsevier.es/sites/default/files/elsevier/pdf/65/65v204n06a13062267pdf001.pdf. Accessed 2012 Oct 20.
25. Wells WA, Ge CF, Patel N, Oh T, Gardiner E, et al. (2011) Size and Usage Patterns of Private TB Drug Markets in the High Burden Countries. PLoS ONE 6(5): e18964 doi:10.1371/journal.pone.0018964.
26. Mor Z, Migliori GB, Althomsons SP, Loddenkemper R, Trnka L, et al. (2008) Comparison of tuberculosis surveillance systems in low-incidence industrialised countries. Eur Respir J 32(6): 1616-1624.
27. Hellenic Statistical Authority (2012) De facto population: Censuses and Mid-year estimates. In: Monthly Statistical Bulletin, April 2012; 57(4): p. 12. Piraeus: ELSTAT. [Accessed September 09, 2012]. Available from: HYPERLINK "http://dlib.statistics.gr/MAG/GRESYE_01_0001_00813.pdf"http://dlib.statistics.gr/MAG/GRESYE_01_0001_00813.pdf. Accessed 2012 Oct 20.